• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PetMed Express Inc.

    10/10/24 6:26:43 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email
    SC 13G 1 ea0217351-13gnina_petmed.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    Information to be Included in Statements Filed Pursuant to §240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to §240.13d-2

     

    Under the Securities Exchange Act of 1934

     

    Petmed Express, Inc.

    (Name of Issuer)

     

    Common Stock, par value $.001 per share

    (Title of Class of Securities)

     

    716382106

    (CUSIP Number)

     

    April 17, 2024

    (Date of Event Which Requires Filing of This Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐Rule 13d-1(b)
    ☒Rule 13d-1(c)
    ☐Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filed out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 2 of 9 Pages

     

    1.

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Nina Capital Holdings Inc.

    2. Check the Appropriate Box if a Member of a Group 

    (a) ☒

    (b) ☐

    3.

    SEC Use Only

     

     

    4.

    Citizenship or Place of Organization

     

    British Virgin Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    Sole Voting Power

     

    0

    6.

    Shared Voting Power

     

    1,550,000

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

     

    1,550,000 

    9.

    Aggregate Amount Owned by Each Reporting Person

     

    1,550,000

    10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  

    ☐

      

    11.

    Percent of Class Represented in Row (9)

     

    7.52%*

    12.

    Type of Reporting Person (See Instructions)

     

    CO

     

    *Based on 20,600,652 shares of Common Stock, $.001 par value per share, at August 7, 2024, as reported on the Issuer’s Form 10-Q as filed with the SEC on August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 3 of 9 Pages

     

    1.

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Moises Tache Galante

    2. Check the Appropriate Box if a Member of a Group 

    (a) ☒

    (b) ☐

    3.

    SEC Use Only

     

     

    4.

    Citizenship or Place of Organization

     

    Spain

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    Sole Voting Power

     

    0

    6.

    Shared Voting Power

     

    2,078,000(1)

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

     

    2,078,000(1)

    9.

    Aggregate Amount Owned by Each Reporting Person

     

    2,078,000(1)

    10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  

    ☐

      

    11.

    Percent of Class Represented in Row (9)

     

    10.08%*

    12.

    Type of Reporting Person (See Instructions)

     

    IN

     

    1)Includes (i) 1,550,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

     

    *Based on 20,600,652 shares of Common Stock, $.001 par value per share, at August 7, 2024, as reported on the Issuer’s Form 10-Q as filed with the SEC on August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 4 of 9 Pages

     

    1.

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Stephannie Matz Zyman

    2. Check the Appropriate Box if a Member of a Group 

    (a) ☒

    (b) ☐

    3.

    SEC Use Only

     

     

    4.

    Citizenship or Place of Organization

     

    Mexico

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    Sole Voting Power

     

    0

    6.

    Shared Voting Power

     

    528,000(1)

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

     

    528,000(1)

    9.

    Aggregate Amount Owned by Each Reporting Person

     

    528,000(1)

    10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  

    ☐

      

    11.

    Percent of Class Represented in Row (9)

     

    2.56%*

    12.

    Type of Reporting Person (See Instructions)

     

    IN

     

    1)Shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

     

    *Based on 20,600,652 shares of Common Stock, $.001 par value per share, at August 7, 2024, as reported on the Issuer’s Form 10-Q as filed with the SEC on August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 5 of 9 Pages

     

    Item 1(a).Name of Issuer.

     

    PetMed Express, Inc.

     

    Item 1(b).Address of Issuer’s Principal Executive Offices.

     

    420 South Congress Avenue,

    Delray Beach, FL, 33445

     

    Item 2(a).Name of Person Filing.

     

    Nina Capital Holdings, Inc.

     

    Item 2(b).Address of Principal Business Office or, if None, Residence.

     

    17301 Biscayne Blvd.

    Apt 2205,

    Aventura, FL 33160

     

    Item 2(c).Citizenship.

     

    British Virgin Islands

     

    Item 2(d).Title of Class of Securities.

     

    Common Stock, $.001 par value per share ("Common Stock")

     

    Item 2(e).CUSIP Number.

     

    716382106

     

    Item 3.If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    (a)☐ Broker or dealer registered under Section 15 of the Exchange Act;

     

    (b)☐ Bank as defined in Section 3(a)(6) of the Exchange Act;

     

    (c)☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act;

     

    (d)☐ Investment company registered under Section 8 of the Investment Company Act.

     

    (e)☐ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     

    (f)☐ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

    (g)☐ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 6 of 9 Pages

     

    (h)☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

     

    (i)☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

     

    (j)☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

     

    Not applicable.

     

    Item 4.Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned: 2,078,000(1)

     

    (b) Percent of class:

     

    10.08%(2)

     

    (c) Number of shares as to which each Reporting Person has:

     

    (i)Sole power to vote or to direct the vote:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 0

    Moises Tache Galante: 0

    Stephannie Matz Zyman: 0

     

    (ii)Shared power to vote or to direct the vote:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 1,550,000

    Moises Tache Galante: 2,078,000(1)

    Stephannie Matz Zyman: 528,000

     

    (iii)Sole power to dispose or to direct the disposition of:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 0

    Moises Tache Galante: 0

    Stephannie Matz Zyman: 0

     

    (iv)Shared power to dispose or to direct the disposition of:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 1,550,000

    Moises Tache Galante: 2,078,000(1)

    Stephannie Matz Zyman: 528,000

     

    (1)Includes (i) 1,550,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

     

    (2)Based on 20,600,652 Common Stock outstanding as of August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 7 of 9 Pages

     

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    See Exhibit A attached.

     

    Item 9.Notice of Dissolution of Groups.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 8 of 9 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: October 10, 2024

     

      Nina Capital Holdings Inc.
         
      By: /s/ Moises Tache Galante
      Name: Moises Tache Galante
      Title: Director

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 9 of 9 Pages

     

    EXHIBIT A

     

    JOINT FILING AGREEMENT

     

    This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of PetMed Express, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1 under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

     

    Dated: October 10, 2024

     

      Nina Capital Holdings Inc.
         
      By: /s/ Moises Tache Galante
      Name:  Moises Tache Galante
      Title: Director
         
      By: /s/ Moises Tache Galante
      Name: Moises Tache Galante
         
      By: /s/ Stephannie Matz Zyman
      Name: Stephannie Matz Zyman

     

     

     

     

     

    Get the next $PETS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    SEC Filings

    See more
    • PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      4/9/25 9:24:45 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 10-Q filed by PetMed Express Inc.

      10-Q - PETMED EXPRESS INC (0001040130) (Filer)

      2/10/25 5:14:56 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      2/10/25 5:12:32 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $PETS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Large owner Nina Capital Holdings Inc. bought $98,375 worth of shares (25,000 units at $3.94), increasing direct ownership by 0.99% to 2,550,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      6/4/25 4:15:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $96,500 worth of shares (25,000 units at $3.86), increasing direct ownership by 1% to 2,525,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/23/25 4:15:13 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Silvercape Investments Ltd bought $29,234 worth of shares (7,401 units at $3.95), increasing direct ownership by 0.32% to 2,307,719 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/22/25 10:55:21 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by PetMed Express Inc.

      SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

      11/14/24 4:02:14 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by PetMed Express Inc.

      SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

      10/10/24 6:26:43 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      2/13/24 5:12:03 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call

      DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We

      5/27/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets

      DELRAY BEACH, Fla. and OAKLAND, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx (NASDAQ:PETS), today announced a new strategic partnership with virtual veterinary care provider Dutch. The collaboration marks PetMeds' latest move to expand its provider ecosystem with affordable, accessible pet healthcare options. The new partnership will enable pet parents to leverage Dutch's convenient technology and veterinary team to secure prescriptions for PetMeds' broad selection of medications in a timely manner. "This partnership expands the accessibility of pet telemedicine, which can help fill gaps in care, as the nationwide vet shortage has

      5/7/25 9:08:06 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

      DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo

      4/11/25 9:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Nina Capital Holdings Inc. bought $98,375 worth of shares (25,000 units at $3.94), increasing direct ownership by 0.99% to 2,550,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      6/4/25 4:15:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $96,500 worth of shares (25,000 units at $3.86), increasing direct ownership by 1% to 2,525,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/23/25 4:15:13 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Silvercape Investments Ltd bought $29,234 worth of shares (7,401 units at $3.95), increasing direct ownership by 0.32% to 2,307,719 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/22/25 10:55:21 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on PetMed Express with a new price target

      Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

      5/25/23 9:17:49 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Morgan Stanley reiterated coverage on PetMed Express with a new price target

      Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

      1/25/22 10:17:17 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti with a new price target

      Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

      1/20/22 9:13:56 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Leadership Updates

    Live Leadership Updates

    See more
    • PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

      DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo

      4/11/25 9:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

      Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors ("the Board"), effective April 09, 2025. Mr. Batushansky is currently a Partner at L2 Capital Partners and brings to the Board more than 20 years of experience across retail, pet, healthcare and private equity, i

      4/9/25 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Robyn D'Elia as Chief Financial Officer

      DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot

      9/12/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Financials

    Live finance-specific insights

    See more
    • PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call

      DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We

      5/27/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

      DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

      2/10/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

      DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

      1/30/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples